Publications in collaboration with researchers from Hospital de Cruces (51)

2024

  1. Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis

    Diabetes Technology and Therapeutics, Vol. 26, Núm. 8, pp. 575-586

  2. ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-related cancer

  3. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

  4. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

    Pituitary, Vol. 27, Núm. 5, pp. 497-506

  5. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433

  6. Natural history and surgical outcomes of Rathke’s cleft cysts: a Spanish multicenter study

    Frontiers in Endocrinology, Vol. 15

  7. Nocturnal Glucose Profile According to Timing of Dinner Rapid Insulin and Basal and Rapid Insulin Type: An Insulclock® Connected Insulin Cap-Based Real-World Study

    Biomedicines, Vol. 12, Núm. 7

  8. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-Related Cancer, Vol. 31, Núm. 7

  9. Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study

    Diabetes Technology and Therapeutics, Vol. 26, Núm. 1, pp. 1-10

2023

  1. Changing trends in transgender demographics and morbidity: baseline data from a Spanish cohort

    Sexual health, Vol. 20, Núm. 1, pp. 96-98

  2. Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial

    Diabetes Care, Vol. 46, Núm. 1, pp. 206-208

  3. Mortality in Acromegaly Diagnosed in Older Individuals in Spain Is Higher in Women Compared to the General Spanish Population

    The Journal of clinical endocrinology and metabolism, Vol. 108, Núm. 9, pp. 2193-2202

  4. RECALSEEN 2021. Resources and quality in the Endocrinology and Nutrition units of the National Health System of Spain

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 7, pp. 459-467

2022

  1. Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019

    Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229

2021

  1. DAPA-RWE: A retrospective multicenter study comparing dapagliflozin and sitagliptin in patients with Type 2 diabetes treated under routine clinical practice in Spain

    Journal of Comparative Effectiveness Research, Vol. 10, Núm. 10, pp. 815-821

  2. Inpatient Hyperglycemia Management and COVID-19

    Diabetes Therapy, Vol. 12, Núm. 1, pp. 121-132

  3. Morphofunctional assessment of patient’s nutritional status: A global approach

    Nutricion Hospitalaria, Vol. 38, Núm. 3, pp. 592-600

2020

  1. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus

    BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1

  2. Effectiveness of sulfonylurea treatment in a patient with a mutation in ABCC8 (MODY12)

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 10, pp. 682-683

  3. Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018

    Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407